Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

Thumbnail
View/ Open

Show full item record
Author
Boykin, Christi; Zhang, G.; Chen, Yan-Hua; Zhang, R-W; Fan, X-E; Yang, W-M; Lu, Q.
URI
http://hdl.handle.net/10342/5298
Date
2011-03
Citation:
APA:
Boykin, Christi, & Zhang, G., & Chen, Yan-Hua, & Zhang, R-W, & Fan, X-E, & Yang, W-M, & Lu, Q.. (March 2011). Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. British Journal of Cancer, 104(5), 781- 789. Retrieved from http://hdl.handle.net/10342/5298

Display/Hide MLA, Chicago and APA citation formats.

MLA:
Boykin, Christi, and Zhang, G., and Chen, Yan-Hua, and Zhang, R-W, and Fan, X-E, and Yang, W-M, and Lu, Q.. "Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation". British Journal of Cancer. 104:5. (781-789), March 2011. September 27, 2023. http://hdl.handle.net/10342/5298.
Chicago:
Boykin, Christi and Zhang, G. and Chen, Yan-Hua and Zhang, R-W and Fan, X-E and Yang, W-M and Lu, Q., "Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation," British Journal of Cancer 104, no. 5 (March 2011), http://hdl.handle.net/10342/5298 (accessed September 27, 2023).
AMA:
Boykin, Christi, Zhang, G., Chen, Yan-Hua, Zhang, R-W, Fan, X-E, Yang, W-M, Lu, Q.. Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. British Journal of Cancer. March 2011; 104(5): 781-789. http://hdl.handle.net/10342/5298. Accessed September 27, 2023.
Collections